# Progress Note 03 — Sick Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Frida Kahlo (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI011-SYN
- Date: 2026-10-08
- Fictional facility: St. Posthumous Health Center
- Fictional author: Marisol Ortega, MD
- Calendar frame: modern shifted

- Visit type: Sick Visit
- Services: Problem-oriented office visit, established patient

## Chief complaint

Sore throat, runny nose, and cough for three days. **S**

## History of present illness

Ms. Kahlo is a 37-year-old woman with chronic post-traumatic back, pelvic, and right leg pain on long-term oxycodone (60 MME a day), who asked for a same-day visit. Her duloxetine was increased to 60 mg a week ago at the rehabilitation visit, and she takes acetaminophen 1 g three times a day. Three days ago she developed a scratchy throat, then a clear runny nose, congestion, and a dry cough. Several of the students who come to her studio have had colds. Home COVID-19 antigen tests on the first and third days were negative. Her highest home temperature was 37.8 °C. Coughing fits jolt her lower back and pelvis, and the pain is worse at night, but she has kept to no more than four oxycodone tablets a day. She bought a nighttime cold and flu liquid at the pharmacy and brought it unopened to ask whether it is safe. Its label lists acetaminophen, dextromethorphan, and doxylamine. She missed one aquatic therapy session. Her oxycodone dose has not changed, and she has had no yawning, gooseflesh, stomach cramps, diarrhea, or restlessness. **S**

| Element | Detail |
|---|---|
| Onset | Three days ago |
| Location | Throat, nose, and chest |
| Duration | Three days |
| Character | Scratchy throat, clear nasal discharge, dry cough |
| Severity | Moderate; coughing fits worsen her back and pelvic pain |
| Timing | Cough worse at night |
| Context | Colds among her students; oxycodone dose unchanged; duloxetine increased a week ago |
| Modifying factors | Warm drinks and honey help; she has not used the cold medicine she bought |
| Associated signs and symptoms | Fatigue. Denies fever above 37.8 °C, breathlessness, wheeze, ear or facial pain, vomiting, and diarrhea |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Fatigue; temperature to 37.8 °C at home; no rigors |
| Ears, nose, mouth, and throat | Positive | Sore throat, clear rhinorrhea, and congestion; no ear pain, facial pain, or trouble swallowing |
| Respiratory | Positive | Dry cough; no breathlessness, wheeze, or sputum |
| Cardiovascular | Negative | No chest pain or palpitations |
| Gastrointestinal | Negative | No nausea, vomiting, abdominal cramps, or diarrhea; bowel habit unchanged |
| Musculoskeletal | Positive | Lower back and pelvic pain worse with coughing; no new injury and no falls |
| Neurological | Negative | Right leg burning unchanged; no new weakness or numbness; no bladder or bowel control change |
| Psychiatric | Negative | Mood steady; sleep broken by cough; no restlessness or anxiety |

8 systems reviewed. **S**

## Current medications

- Oxycodone 10 mg oral tablet, one tablet every 6 hours as needed for pain, no more than four a day (60 MME a day) **S**
- Duloxetine 60 mg delayed-release oral capsule, one capsule daily **S**
- Acetaminophen 500 mg oral tablet, two tablets three times daily **S**
- Diclofenac sodium 1% topical gel, 2 g to the right ankle four times daily **S**
- Cholecalciferol (vitamin D3) 2,000 units oral tablet, one tablet daily **S**
- Naloxone 4 mg nasal spray, one spray into one nostril for suspected opioid overdose; may repeat in the other nostril **S**

## Allergies

- No known allergy **S**

## Objective

BP 118/72 mmHg; pulse 88 bpm; respirations 16/min; temperature 37.6 °C; oxygen saturation 98% on room air; weight 50 kg; BMI 19.5 kg/m². All vital signs are synthetic.

PEG pain and function score (0-10): 7. All results are synthetic.

## Change since baseline

- PEG pain and function score (0-10): 7.3 at baseline, 7 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Alert, congested, and talkative; seated with her cane beside her; not drowsy |
| Eyes | Pupils equal, 4 mm, and reactive; no tearing |
| Ears, nose, and throat | Tympanic membranes normal; nasal mucosa red and swollen with clear discharge; pharynx mildly red without exudate or tonsillar swelling |
| Neck | Small, soft, mildly tender anterior cervical nodes |
| Respiratory | Unlabored; clear to auscultation; no crackles or wheeze |
| Cardiovascular | Regular rhythm; no murmur |
| Musculoskeletal | Lumbar paraspinal tenderness as at intake; healed lumbar surgical scars; gait with cane and limp unchanged |
| Neurological | Right leg strength and sensation unchanged from intake |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Acute viral upper respiratory infection (common cold)** (J06.9). Cough and runny nose point to a viral cause, so a strep test is not needed. Temperature 37.6 °C, heart rate 88, respiratory rate 16, oxygen saturation 98 percent, and a clear chest make pneumonia unlikely. A chest radiograph and antibiotics are not indicated. **S**
   - Supportive care: honey in warm drinks, saline nasal spray, throat lozenges, and rest.
   - Keep her scheduled acetaminophen at 1 g three times a day. It also treats the sore throat and fever. Take no other product containing acetaminophen, because she is already at the 3 g daily limit.
   - Do not use the nighttime cold liquid. Doxylamine adds sedation and slows breathing with oxycodone, dextromethorphan with duloxetine raises the risk of serotonin toxicity, and its acetaminophen would exceed her daily limit.
   - Avoid codeine or hydrocodone cough syrups and sedating antihistamines. Oral NSAIDs are not added, because with duloxetine they raise the risk of stomach bleeding and she already uses diclofenac gel.
   - Repeat a home COVID-19 antigen test in 48 hours. If it is positive, call the same day. Her mobility disability makes her eligible for antiviral treatment, and ritonavir-boosted nirmatrelvir raises oxycodone levels, so any antiviral needs a drug-interaction review first.
   - The cough may last up to two to three weeks.
2. **Long-term opioid therapy, 60 MME a day** (Z79.891). No sedation; pupils normal. Her symptoms are not opioid withdrawal: the dose has not changed, and the fever, sore throat, and sick contacts point to infection. A respiratory infection and sedating cold medicines both add to opioid risk. **S**
   - Continue oxycodone 10 mg up to four times a day, with no extra doses.
   - Naloxone nasal spray confirmed at home and in date; reviewed when to use it.
   - The first dose reduction stays planned for next week's visit if she has recovered. If she is still unwell, it can move by a week, as the taper plan allows.
3. **Chronic post-traumatic back and pelvic pain, aggravated by coughing** (G89.21). PEG 7.0, the same as at the rehabilitation visit. No red flags: no new neurological deficit, no bladder or bowel change, no fall, and no high fever. **S**
   - Hug a pillow against the abdomen when coughing; heat to the lower back.
   - Continue duloxetine 60 mg daily and the gentle home exercises.
   - Pause aquatic therapy until she has been fever-free for 24 hours, then resume.

## Guideline basis

- CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022), Centers for Disease Control and Prevention (MMWR Recommendations and Reports)
- Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention (2016), American College of Physicians and Centers for Disease Control and Prevention

## Follow-up

- Next scheduled visit in one week. Call or return sooner for a temperature above 38.3 °C, breathlessness, symptoms that worsen after improving or last beyond ten days, or new leg weakness. Anyone with her who finds her very drowsy or breathing slowly should give naloxone and call 911. **S**
- Next scheduled visit 2026-10-15: four-week chronic pain follow-up with the first opioid dose reduction. **S**
